Basic info
Industry
biotechnology research
Sectors
Biotechnology
Antibody-Drug Conjugates
Therapeutics
Cancer
ADCs
Health Care
Nuclear Delivery PlatformTM
Oncology
Nuclear-Delivered Antibody-Drug ConjugatesTM
Date founded
2015
Funding rounds raised
Total raised
$25M
from 4 investors over 4 rounds
A
Angiex Inc. raised $25M on April 9, 2021
Investors: Presight Capital and Thiel Capital
A
Angiex Inc. raised $2M on October 8, 2020
Investors: Presight Capital
A
Angiex Inc. raised $3M on July 3, 2017
Investors: Thiel Capital